Guest guest Posted May 2, 2008 Report Share Posted May 2, 2008 info, UNEXPECTED_DATA_AFTER_ADDRESS@.SYNTAX-ERROR. wrote: shac-ukFrom: info <infoThu, 1 May 2008 16:24:51 -0700 (PDT)[shac-uk] ACTION ALERT :: PUT THE PRESSURE ON ORION PHARMAHLS Customer - Orion Pharma============================Orion Pharma are one of the companies feeding Huntingdon the profits they needto survive. If it weren't for these companies paying them, then HLS simplywouldn't have enough money to continue.We need to inform the workers of these companies just what happens insideHuntingdon. Take action by contacting the employees of Orion Pharma to explain to them justexactly what does go on behind the razor wire.There is a sample letter below if you wish to use it. Please remember to remainpolite at all times.Sample Letter==========Dear Sir/MadamYou may not be aware that HLS is the worlds most exposed animal testinglaboratory. They have been caught out on film several times committing acts ofcruelty both in the US and the UK. They have been caught punching beaglespuppies, and cutting open live primates without pain killers. They have beenexposed for shoddy work, and falsified data. During one study on wild caughtbaboons HLS broke the law over 520 times but were never prosecuted.Last year, a senior scientist from HLS in the USA has filed a lawsuit after heclaims he was being pressured into falsifying data. This is a sham of a company with a poor reputation and I should not think you would like to beassociated with this.I don't expect you to take my word for it but you can see the cruelty yourself, as shown on national TV: http://www.shac.net/HLS/exposed.html. Forother exposes into HLS, see: http://www.shac.net/MISC/Inside_HLS.htmlI urge Orion Pharma to stop dealing with a lab involved in such horrific animalcruelty.Thank you for your time, and I do hope that you will be reconsidering yourposition and will not supply HLS.Yours sincerely,Contacts=============Heikki.Vuonamo- Corporate Vice President, CommunicationsTel. +358 10 429 4967Fax +358 10 429 4435 Anne.Allo- Vice President, Investor RelationsTel +358 10 429 3735Fax +358 10 429 4435Tuula.Laitinen- Communications ManagerTel. +358 10 429 2136Fax +358 10 429 4435jari.karlson- Chief Financial OfficerTel. +358 10 429 2883Fax +358 10 429 4599aino.takala- Head of Strategic Planning, Orion PharmaTel. +358 10 429 4503Fax +358 10 429 4503All Emails for Orion Group (3 blocks of 22)==================================Heikki.Vuonamo, Anne.Allo, Tuula.Laitinen, jari.karlson, aino.takala, Minna.Lyhykainen, Tarja.Nurmi, tutkimusyksikko, tutkimusinfo, anja.koskinen, pekka.kaivola, juha.ellmen, jobs, timo.lappalainen, markku.huhta-koivisto, pekka.kairisalo, fermionSales, pekka.jarvensivu, animalhealth, esa.heinonen, andrea.buelermoos, evelyne.buetlerantti.haapalinna, licensing, info, opdk, norway, tomas.gloveus, ken.tinebo, frank.pegelow, renate.wannewitz, info.hamburg, info.switzerland, elling.berg, norweb, elin.michaelsen, paivi.pajunen, orion.diagnostica, info, firmapost, orion, minna.lyhykainen, flavia.diener, heikki.vuonamotuula.laitinen, corpcom, christer.lundin, ann.rodriguez, contact.sweanimal, susanna.kaas, knut.thorbjornsen, kari-anne.solli, gunilla.tangen, hanne.risheim, vegar.skreden, annkristin.nygaard, andreas.bjordal, ernst.hoff, ritva.kivirinta, cmo, anne.allo, pia.bolinder, daniel.rammin, beat.wiesli, amparin.mandingorraWebsites===========http://www.orion.fi/english/http://www.oriondiagnostica.fi/http://www.orionpharma.se/Locations===========Orion Corporation Orion Pharma Orionintie 1, FI-02200 EspooP.O. Box 65, FI-02101 EspooTel: +358 10 4291Fax: +358 10 429 3815ORION PHARMA AGUnterm¸li 11CH-6300 Zug / SwitzerlandTel: +41 41 767 40 90Tel: +41 41 767 40 94Fax: +41 41 767 40 99www.orionpharma.ch http://pets.Fortheanimals7/join http://www.myspace.com/fortheanimals7 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.